Grassi Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.98M | Sell |
107,610
-750
| -0.7% | -$36.8K | 0.4% | 52 |
|
|
2025
Q1 | $6.61M | Hold |
108,360
| – | – | 0.61% | 43 |
|
|
2024
Q4 | $6.13M | Hold |
108,360
| – | – | 0.52% | 45 |
|
|
2024
Q3 | $5.61M | Sell |
108,360
-400
| -0.4% | -$18.8K | 0.48% | 47 |
|
|
2024
Q2 | $4.52M | Sell |
108,760
-100
| -0.1% | -$4.47K | 0.4% | 49 |
|
|
2024
Q1 | $5.9M | Hold |
108,860
| – | – | 0.53% | 46 |
|
|
2023
Q4 | $5.59M | Buy |
108,860
+300
| +0.3% | +$15.7K | 0.59% | 45 |
|
|
2023
Q3 | $6.3M | Hold |
108,560
| – | – | 0.72% | 42 |
|
|
2023
Q2 | $6.94M | Sell |
108,560
-1,700
| -2% | -$114K | 0.76% | 43 |
|
|
2023
Q1 | $7.64M | Buy |
110,260
+1,700
| +2% | +$120K | 0.95% | 38 |
|
|
2022
Q4 | $7.81M | Hold |
108,560
| – | – | 1.05% | 38 |
|
|
2022
Q3 | $7.72M | Hold |
108,560
| – | – | 1.12% | 35 |
|
|
2022
Q2 | $8.36M | Hold |
108,560
| – | – | 1.1% | 35 |
|
|
2022
Q1 | $7.93M | Buy |
108,560
+1,800
| +2% | +$121K | 0.83% | 47 |
|
|
2021
Q4 | $6.66M | Sell |
106,760
-600
| -0.6% | -$35.2K | 0.67% | 51 |
|
|
2021
Q3 | $6.35M | Hold |
107,360
| – | – | 0.71% | 49 |
|
|
2021
Q2 | $7.17M | Sell |
107,360
-32,422
| -23% | -$2.11M | 0.78% | 44 |
|
|
2021
Q1 | $8.82M | Sell |
139,782
-3,273
| -2% | -$204K | 1% | 34 |
|
|
2020
Q4 | $8.87M | Sell |
143,055
-13,848
| -9% | -$852K | 1.13% | 34 |
|
|
2020
Q3 | $9.46M | Buy |
156,903
+2,426
| +2% | +$146K | 1.34% | 31 |
|
|
2020
Q2 | $9.08M | Buy |
154,477
+1,152
| +0.8% | +$68.9K | 1.31% | 33 |
|
|
2020
Q1 | $8.55M | Buy |
153,325
+16,135
| +12% | +$986K | 1.49% | 24 |
|
|
2019
Q4 | $8.81M | Buy |
137,190
+3,625
| +3% | +$208K | 1.19% | 33 |
|
|
2019
Q3 | $6.77M | Buy |
133,565
+10,300
| +8% | +$484K | 1.02% | 45 |
|
|
2019
Q2 | $5.59M | Buy |
123,265
+51,849
| +73% | +$2.42M | 0.83% | 53 |
|
|
2019
Q1 | $3.41M | Hold |
71,416
| – | – | 0.5% | 60 |
|
|
2018
Q4 | $3.71M | Hold |
71,416
| – | – | 0.64% | 58 |
|
|
2018
Q3 | $4.43M | Hold |
71,416
| – | – | 0.66% | 58 |
|
|
2018
Q2 | $3.95M | Sell |
71,416
-12,940
| -15% | -$699K | 0.63% | 59 |
|
|
2018
Q1 | $5.34M | Buy |
84,356
+2,500
| +3% | +$161K | 0.87% | 54 |
|
|
2017
Q4 | $5.02M | Buy |
81,856
+150
| +0.2% | +$9.38K | 0.81% | 53 |
|
|
2017
Q3 | $5.21M | Hold |
81,706
| – | – | 0.88% | 48 |
|
|
2017
Q2 | $4.55M | Sell |
81,706
-100
| -0.1% | -$5.44K | 0.8% | 52 |
|
|
2017
Q1 | $4.45M | Hold |
81,806
| – | – | 0.77% | 56 |
|
|
2016
Q4 | $4.78M | Sell |
81,806
-31,483
| -28% | -$1.72M | 0.87% | 49 |
|
|
2016
Q3 | $6.11M | Buy |
113,289
+527
| +0.5% | +$33.9K | 1.15% | 38 |
|
|
2016
Q2 | $8.29M | Sell |
112,762
-173
| -0.2% | -$12.2K | 1.57% | 17 |
|
|
2016
Q1 | $7.21M | Sell |
112,935
-3,409
| -3% | -$215K | 1.43% | 25 |
|
|
2015
Q4 | $8M | Sell |
116,344
-1,166
| -1% | -$77.1K | 1.64% | 12 |
|
|
2015
Q3 | $6.96M | Sell |
117,510
-2,646
| -2% | -$168K | 1.48% | 17 |
|
|
2015
Q2 | $8M | Buy |
120,156
+407
| +0.3% | +$26.8K | 1.5% | 9 |
|
|
2015
Q1 | $7.72M | Buy |
119,749
+206
| +0.2% | +$12.9K | 1.43% | 12 |
|
|
2014
Q4 | $7.06M | Buy |
119,543
+197
| +0.2% | +$11.1K | 1.24% | 17 |
|
|
2014
Q3 | $6.11M | Buy |
119,346
+706
| +0.6% | +$35.3K | 1.16% | 30 |
|
|
2014
Q2 | $5.75M | Sell |
118,640
-1,943
| -2% | -$95.8K | 1.26% | 31 |
|
|
2014
Q1 | $6.26M | Buy |
120,583
+1,606
| +1% | +$85.5K | 1.48% | 19 |
|
|
2013
Q4 | $6.32M | Buy |
118,977
+1,062
| +0.9% | +$54.1K | 1.51% | 17 |
|
|
2013
Q3 | $5.46M | Buy |
117,915
+3,000
| +3% | +$132K | 1.44% | 20 |
|
|
2013
Q2 | $5.14M | Buy |
+114,915
| New | +$4.99M | 1.38% | 16 |
|
Other funds holding BMY
Grassi Investment Management's BMY Position: Q2 2025 in Review
Grassi Investment Management reduced its Bristol-Myers Squibb (BMY) stake by 0.69% in Q2 2025, selling an estimated $36.8K and leaving 107,610 shares worth $4.98M. The position accounts for 0.4% of the portfolio, ranked #52.
Grassi Investment Management first reported a position in BMY in Q2 2013 and has held it in 49 quarters since. The position peaked at $9.46M in Q3 2020. 2,292 funds tracked by Wall St. Rank hold BMY as of Q2 2025.
- Grassi Investment Management held 107,610 shares of Bristol-Myers Squibb worth $4.98M as of Q2 2025.
- Grassi Investment Management sold 750 Bristol-Myers Squibb shares in Q2 2025, an estimated $36.8K.
- Bristol-Myers Squibb made up 0.4% of Grassi Investment Management's portfolio in Q2 2025, its #52 holding.
- Grassi Investment Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 49 quarters since.
- Grassi Investment Management's Bristol-Myers Squibb position peaked at $9.46M in Q3 2020.
- 2,292 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.
Based on Grassi Investment Management's 13F filing for Q2 2025, filed 21 Jul 2025.